DCs lacking CD1d reduce IL-10 production by NKT cells, and the administration of IL-10 to CD1d-KO mice may significantly reverse Ang II-induced hypertension and cardiac remodeling by activating STAT3 and inhibiting the TGF-β1 and NF-kB signaling pathways197,198. This evidence concerns the gene IL10 and hypertensive disorder.